Literature DB >> 25337926

Central insulin administration improves odor-cued reactivation of spatial memory in young men.

Yvonne F Brünner1, Anja Kofoet, Christian Benedict, Jessica Freiherr.   

Abstract

CONTEXT: Insulin receptors are ubiquitously found in the human brain, comprising the olfactory bulb, essential for odor processing, and the hippocampus, important for spatial memory processing.
OBJECTIVE: The present study aimed at examining if intranasal insulin, which is known to transiently increase brain insulin levels in humans, would improve odor-cued reactivation of spatial memory in young men.
DESIGN: We applied a double-blind, placebo-controlled, counterbalanced within-subject design.
SETTING: The study was conducted at the research unit of a university hospital. Interventions/Participants/Main Outcome Measures: Following intranasal administration of either insulin (40 I.U.) or placebo, male subjects (n = 18) were exposed to eight odors. During each odor exposure, a green-colored field was presented on a 17-in. computer screen. During immediate recall (comprising 3 runs), the participants were re-exposed to each odor cue, and were asked to select the corresponding field (with visual feedback after each response). The delayed recall was scheduled ∼10 min later (without feedback). To test if insulin's putative effect on odor-place memory would be domain-specific, participants also performed a separate place and odor recognition task.
RESULTS: Intranasal insulin improved the delayed but not immediate odor-cued recall of spatial memory. This effect was independent of odor type and in the absence of systemic side effects (eg, fasting plasma glucose levels remained unaltered). Place and odor recognition were unaffected by the insulin treatment.
CONCLUSIONS: These findings suggest that acute intranasal insulin improves odor-cued reactivation of spatial memory in young men.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25337926     DOI: 10.1210/jc.2014-3018

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Insulin resistance is associated with poorer verbal fluency performance in women.

Authors:  Laura L Ekblad; Juha O Rinne; Pauli J Puukka; Hanna K Laine; Satu E Ahtiluoto; Raimo O Sulkava; Matti H Viitanen; Antti M Jula
Journal:  Diabetologia       Date:  2015-08-15       Impact factor: 10.122

Review 2.  Calcium's role as nuanced modulator of cellular physiology in the brain.

Authors:  Hilaree N Frazier; Shaniya Maimaiti; Katie L Anderson; Lawrence D Brewer; John C Gant; Nada M Porter; Olivier Thibault
Journal:  Biochem Biophys Res Commun       Date:  2016-08-20       Impact factor: 3.575

3.  Learning and memory performance following acute intranasal insulin administration in abstinent smokers.

Authors:  Ajna Hamidovic; Lionel Candelaria; Ihsan Rodriguez; Mikiko Yamada; James Nawarskas; Mark R Burge
Journal:  Hum Psychopharmacol       Date:  2018-01-24       Impact factor: 1.672

4.  Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents.

Authors:  H N Frazier; K L Anderson; S Maimaiti; A O Ghoweri; S D Kraner; G J Popa; K K Hampton; M D Mendenhall; C M Norris; R J Craven; O Thibault
Journal:  Neurochem Res       Date:  2018-03-23       Impact factor: 3.996

5.  Awake, long-term intranasal insulin treatment does not affect object memory, odor discrimination, or reversal learning in mice.

Authors:  Genevieve A Bell; Debra Ann Fadool
Journal:  Physiol Behav       Date:  2017-03-02

6.  Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging.

Authors:  Shaniya Maimaiti; Katie L Anderson; Chris DeMoll; Lawrence D Brewer; Benjamin A Rauh; John C Gant; Eric M Blalock; Nada M Porter; Olivier Thibault
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-02-06       Impact factor: 6.053

Review 7.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

8.  Impact of Single or Repeated Dose Intranasal Zinc-free Insulin in Young and Aged F344 Rats on Cognition, Signaling, and Brain Metabolism.

Authors:  Katie L Anderson; Hilaree N Frazier; Shaniya Maimaiti; Vikas V Bakshi; Zana R Majeed; Lawrence D Brewer; Nada M Porter; Ai-Ling Lin; Olivier Thibault
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-04-10       Impact factor: 6.053

Review 9.  Intranasal insulin and orexins to treat age-related cognitive decline.

Authors:  Jennifer M Erichsen; Coleman B Calva; Lawrence P Reagan; Jim R Fadel
Journal:  Physiol Behav       Date:  2021-02-21

Review 10.  Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease.

Authors:  Barbara Miziak; Barbara Błaszczyk; Stanisław J Czuczwar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.